Paul Tudor Jones II acquired 114k Advanced Micro Devices shares worth $61.2M. That's 0.31% of their equity portfolio (55th largest holding). The first Advanced Micro Devices trade was made in Q2 2016. Since then Paul Tudor Jones II bought shares 41 more times and sold shares on 35 occasions. The stake costed the investor $13.1M, netting the investor a gain of 366% so far.
SEATTLE--(BUSINESS WIRE)-- #DryAMD--LumiThera's LIGHTSITE IIIB Extension Trial Topline Results Show Extended Vision Improvement in Dry AMD Subjects Treated w...
PARIS, Feb. 13, 2025 (GLOBE NEWSWIRE) -- PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies w...
Regenxbio's rolling BLA submission completion of RGX-121 for the treatment of patients with MPS II expected in Q1 of 2025. Partnership established with Nippo...
Regenxbio Inc. remains undervalued despite its cutting-edge AAV gene therapy technology and promising assets like RGX-314 for wet AMD and RGX-121 for MPS II....